Nephrolithiasis: Clinical Trials

50 trials for Nephrolithiasis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

29 completed, 9 unknown, 4 not yet recruiting, 4 terminated. 50 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 450Completed 29, Unknown 9, Not yet recruiting 4, Terminated 4, Recruiting 3, Withdrawn 1

Follow Nephrolithiasis: new trials by email Literature Review of Nephrolithiasis trials Research Report on Nephrolithiasis

Trials (filtered) newest first · largest first

All 50 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Randomized, Double-Blind, Placebo-Controlled Trial of Anrikefon for Postoperative Analgesia After Percutaneous Nephrolithotomy
0.9% Sodium Chloride Injection as Placebo, Anrikefon - Postoperative Pain, Nephrolithiasis
Phase 4Not yet recruitingBeijing Tsinghua Chang Gung Hospital1602026-10-122026-09-17
Pain Control During ESWL Using Non-Opioid Analgesics
Ibuprofen (Brufen®), Paracetamol (drug), Tenoxicam - Urolithiasis, Kidney Stones
Phase 4Not yet recruitingUniversity of Gaziantep1602026-10-012026-08-12
Effect of a Low-Dose Ketamine-Dexmedetomidine-Based Opioid-Sparing Anesthesia Protocol on Postoperative Quality of Recovery After Percutaneous Nephrolithotomy
Ketamine and Dexmedetomidine, Fentanyl - Nephrolithiasis, Postoperative Pain
Phase 4Not yet recruitingAssiut University1002026-10-012026-10-02
The Clinical Research of Traditional Chinese Medicine Formula
Bushen Huoxue Simiao Formula, control group - Urologic Injuries, Kidney Disease
Phase 4Not yet recruitingThe Fourth Affiliated Hospital of Zhejiang University School of Medicine802026-08-312026-08-04
CaOx Stone Prevention
Chlorthalidone, Low oxalate diet - Kidney Stones
Phase 4RecruitingIcahn School of Medicine at Mount Sinai802025-10-232026-08-14
Combined Intravenous and Irrigation Tranexamic Acid During Percutaneous Nephrolithotomy
Tranexamic acid, Normal Saline - Kidney Stones, Surgical Blood Loss
Phase 4CompletedBenha University902025-06-302026-10-30
Retrograde Intrarenal Surgery Low Risk Trial
Levofloxacin, Cefmetazole (drug) - Retrograde Intrarenal Surgery, Renal Stones
Phase 4UnknownNational Taiwan University Hospital2002024-12-042024-12-19
Exploratory Study on the Treatment of Gout With Potassium Citrate Sustained-release Tablets
Sodium Bicarbonate Oral Capsule, Potassium Citrate Tablets, uric-acid-lowering drug - Hyperuricemia or Gout, Nephrolithiasis
Phase 4RecruitingHuashan Hospital3122024-04-102025-05-13
Alpha-Blockers Prior to Ureteral Access Sheath Placement in Flexible Ureteroscopy: A Randomized Prospective Study
Experimental: Alpha-blocker group, No intervention (observational study) - Nephrolithiasis, Alpha Blocker
Phase 4RecruitingPedro de Figueiredo Buchalla1402024-01-012025-08-15
Preoperative Prophylactic Antibiotic Duration in Moderate to High Risk Ureteroscopy
Duration of antibiotics - Infections, Urinary Tract, Nephrolithiasis
Phase 4TerminatedUniversity of California, San Francisco342024-01-012026-11-12
Narcotic-Free Percutaneous Nephrolithotomy
5mg Oxycodone, Q6 PRN, 10mg Ketorolac, Q6 PRN - Nephrolithiasis
Phase 4CompletedIcahn School of Medicine at Mount Sinai902023-05-192025-03-26
Empiric Versus Selective Prevention Strategies for Kidney Stone Disease
Empiric Therapy: Diet, Empiric Therapy: Drug, Selective Therapy: Diet - Kidney Stones, Nephrolithiasis
Phase 4CompletedVanderbilt University Medical Center562022-08-042026-10-05
THE EFFECTS OF MIRABEGRON AND TAMSULOSIN FOR PATIENTS WITH URETERAL STENTS
Mirabegron 50 MG - Ureteral Stone, Kidney Stones
Phase 4CompletedHasanuddin University422022-07-012023-11-13
Continuous Erector Spinae Plane Blocks to Treat Pain Following Percutaneous Nephrolithotomy
Active bupivacaine 0.25% via an erector spinae plane perineural catheter, Placebo normal saline via an erector spinae plane perineural catheter - Pain, Acute Postoperative, Renal Stone
Phase 4CompletedUniversity of California, San Diego502022-03-162026-10-07
Tranexamic Acid to Improve Same-day Discharge Rates After Holmium Laser Enucleation of the Prostate (HoLEP)
Tranexamic acid - Kidney Calculi, Urologic Diseases
Phase 4CompletedNorthwestern University1102021-09-172026-10-15
Allopurinol Effect on MDA,NO,KIM-1 Urine Levels, RI and Renal Elastography in Kidney Stone Patients Post ESWL
Allopurinol Tablet 300 mg, Control Group - Kidney Calculi
Phase 4CompletedRSUP Prof. Dr. I.G.N.G. Ngoerahal352020-08-062022-06-10
Regional Erector Spinae Analgesic Block vs Standard of Care Undergoing Percutaneous Nephrolithotomy
4mg PF Dexamethasone, Control Test - Kidney Stone, Surgery
Phase 4TerminatedIndiana University52020-02-242021-04-23
Pathogenesis of Uric Acid Nephrolithiasis: Role of Pioglitazone/Weight Loss
Pioglitazone 45 mg, Weight Loss, Pioglitazone + Weight Loss - Nephrolithiasis, Uric Acid
Phase 4CompletedUniversity of Texas Southwestern Medical Center292019-10-172026-08-31
Opioid Free Management After Ureteroscopy
Norco 5milligram-325milligram Tablet, Ibuprofen 400 MILLIGRAM in 1 TABLET ORAL TABLET, FILM COATED - Kidney Stone
Phase 4CompletedWake Forest University Health Sciences222019-09-192021-03-11
Effectiveness of Urinary Alkalinizing Agents on Kidney Stone Risk
Baking Soda, LithoLyte - Kidney Stone
Phase 4CompletedUniversity of Wisconsin, Madison312019-08-282021-11-22

Showing 20 of 50. Sign in to see all of them.

Narrower conditions

Kidney Calculi (29)  ·  Urolithiasis (7)  ·  Pain (5)  ·  Pain, Postoperative (5)  ·  Calculi (3)  ·  Lower Urinary Tract Symptoms (3)  ·  Ureteral Calculi (3)  ·  Ureterolithiasis (3)  ·  Urinary Tract Infections (3)  ·  Agnosia (2)  ·  Acidosis (1)  ·  Bites and Stings (1)  ·  Blood Loss, Surgical (1)  ·  Body Weight (1)

Broader conditions

Female Urogenital Diseases (50)  ·  Female Urogenital Diseases and Pregnancy Complications (50)  ·  Male Urogenital Diseases (50)  ·  Urogenital Diseases (50)  ·  Kidney Diseases (49)  ·  Urologic Diseases (49)  ·  Urolithiasis (43)  ·  Pathological Conditions, Signs and Symptoms (38)  ·  Pathological Conditions, Anatomical (31)  ·  Urinary Calculi (31)  ·  Calculi (28)  ·  Signs and Symptoms (15)  ·  Neurologic Manifestations (12)  ·  Pain (7)

Interventions

Tamsulosin (6)  ·  Ketorolac (4)  ·  Oxycodone (4)  ·  Acetaminophen (3)  ·  Tranexamic Acid (3)  ·  Allopurinol (2)  ·  Ciprofloxacin (2)  ·  Control Groups (2)  ·  Ketorolac Tromethamine (2)  ·  Nitrofurantoin (2)  ·  Pharmaceutical Preparations (2)  ·  Potassium Citrate (2)  ·  Sodium Bicarbonate (2)  ·  Sodium Chloride (2)  ·  mirabegron (2)

Sponsors

Diskapi Teaching and Research Hospital (4)  ·  Icahn School of Medicine at Mount Sinai (2)  ·  Mansoura University (2)  ·  University of California, San Diego (2)  ·  University of California, San Francisco (2)  ·  Albert Einstein Healthcare Network (1)  ·  Andrew Meltzer (1)  ·  Assiut University (1)  ·  Barrie Urology Associates (1)  ·  Beijing Tsinghua Chang Gung Hospital (1)  ·  Benha University (1)  ·  Clinical Urology and Epidemiology Working Group (1)  ·  Coloplast A/S (1)  ·  Hadassah Medical Organization (1)  ·  Hasanuddin University (1)

Countries

United States (20)  ·  Canada (5)  ·  Turkey (Türkiye) (5)  ·  Brazil (3)  ·  Egypt (3)  ·  Indonesia (3)  ·  France (2)  ·  China (1)  ·  Finland (1)  ·  Iran (1)  ·  Ireland (1)  ·  Israel (1)  ·  Italy (1)  ·  Russia (1)  ·  Saudi Arabia (1)

Top investigators

Mantu Gupta, MD (2)  ·  Nihat Karakoyunlu, MD (2)  ·  Ahmed A. Shokeir, MD (1)  ·  Ahmed R. EL-Nahas, MD (1)  ·  Andrea G Lantz, MD (1)  ·  Andrew C Meltzer, MD (1)  ·  Angel D Valdez-Vargas, MD (1)  ·  Bannakij Lojanapiwat, MD (1)  ·  Ben Chew, MD (1)  ·  Brian M Ilfeld, MD, MS (1)  ·  Chad Tracy, MD (1)  ·  Clifford Rosen, MD (1)  ·  Daniel L Miller, MD MPH (1)  ·  Deok Hyun Han, M.D. (1)  ·  Edel R Rodea-Montero, MPH (1)

Results publications

PMID 25443519, PMID 15208882, PMID 16037145, PMID 19901004, PMID 22093679, PMID 23058854, PMID 24976224, PMID 27890522, PMID 29913020, PMID 31153628, PMID 33213185, PMID 33630393, PMID 34564842, PMID 35685573, PMID 36222618, PMID 37955353, PMID 42617398

NIH funding

2015 (1), U01DK071603 (1), U01DK096037 (1), U34DK090957 (1)